The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges
- 15 March 2011
- journal article
- review article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 36 (2) , 49-59
Abstract
The concept of prodrugs has been successfully executed for life cycle management options of several approved drugs and drugs in development. In addition to imparting ideal biopharmaceutical properties, such as solubility, permeability and lipophilicity, some prodrug concepts have also enabled site-specific drug delivery, prolonged the duration of therapeutic effect and improved therapeutic index. The strategic inclusion of prodrug concept during drug discovery and early development process brings in some unique challenges. The communication provides balanced perspectives on the rational use and challenges of prodrug concept during the drug discovery and development process.Keywords
This publication has 55 references indexed in Scilit:
- Overview of strategies for addressing BRIs in drug discovery: Impact on optimization and designChemico-Biological Interactions, 2011
- Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure InfectionsAntimicrobial Agents and Chemotherapy, 2011
- Enhancing the Intestinal Absorption of Molecules Containing the Polar Guanidino Functionality: A Double-Targeted Prodrug ApproachJournal of Medicinal Chemistry, 2009
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2009
- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial AgentAntimicrobial Agents and Chemotherapy, 2009
- Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuseJournal of Psychopharmacology, 2009
- Hydrolysis of Dinitrobenzamide Phosphate Prodrugs: The Role of Alkaline PhosphataseDrug Metabolism and Drug Interactions, 2009
- Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to PatientsAntimicrobial Agents and Chemotherapy, 2008
- Toxicity Profile of Lisdexamfetamine Dimesylate in Three Independent Rat Toxicology StudiesBasic & Clinical Pharmacology & Toxicology, 2007
- Plasma Amprenavir Pharmacokinetics and Tolerability following Administration of 1,400 Milligrams of Fosamprenavir Once Daily in Combination with either 100 or 200 Milligrams of Ritonavir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2007